As of 2025-11-18, the EV/EBITDA ratio of Abingdon Health PLC (ABDX.L) is -10.26. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ABDX.L's latest enterprise value is 19.84 mil GBP. ABDX.L's TTM EBITDA according to its financial statements is -1.93 mil GBP. Dividing these 2 quantities gives us the above ABDX.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.4x - 9.8x | 9.6x |
| Forward P/E multiples | 10.6x - 14.6x | 12.6x |
| Fair Price | (8.56) - (7.95) | (8.95) |
| Upside | -214.2% - -206.0% | -219.3% |
| Date | EV/EBITDA |
| 2025-11-17 | -10.32 |
| 2025-11-14 | -10.04 |
| 2025-11-13 | -10.29 |
| 2025-11-12 | -9.97 |
| 2025-11-11 | -10.70 |
| 2025-11-10 | -11.49 |
| 2025-11-07 | -10.04 |
| 2025-11-06 | -9.96 |
| 2025-11-05 | -9.84 |
| 2025-11-04 | -8.69 |
| 2025-11-03 | -8.70 |
| 2025-10-31 | -8.44 |
| 2025-10-30 | -8.66 |
| 2025-10-29 | -8.67 |
| 2025-10-28 | -8.69 |
| 2025-10-27 | -8.70 |
| 2025-10-24 | -8.74 |
| 2025-10-23 | -8.66 |
| 2025-10-22 | -8.67 |
| 2025-10-21 | -8.69 |
| 2025-10-20 | -8.70 |
| 2025-10-17 | -8.74 |
| 2025-10-16 | -8.66 |
| 2025-10-15 | -8.67 |
| 2025-10-14 | -8.69 |
| 2025-10-13 | -8.44 |
| 2025-10-10 | -8.48 |
| 2025-10-09 | -8.21 |
| 2025-10-08 | -8.35 |
| 2025-10-07 | -8.36 |
| 2025-10-06 | -8.38 |
| 2025-10-03 | -8.41 |
| 2025-10-02 | -8.27 |
| 2025-10-01 | -8.61 |
| 2025-09-30 | -8.17 |
| 2025-09-29 | -8.18 |
| 2025-09-26 | -8.15 |
| 2025-09-25 | -8.08 |
| 2025-09-24 | -8.09 |
| 2025-09-23 | -8.10 |
| 2025-09-22 | -8.12 |
| 2025-09-19 | -8.15 |
| 2025-09-18 | -8.08 |
| 2025-09-17 | -8.09 |
| 2025-09-16 | -8.10 |
| 2025-09-15 | -8.12 |
| 2025-09-12 | -8.09 |
| 2025-09-11 | -8.01 |
| 2025-09-10 | -8.02 |
| 2025-09-09 | -8.04 |